This study investigates locally unresectable pancreatic cancer. The purpose is to explore if surgery after chemotherapy can improve survival and quality of life.
The study evaluates the effects of surgery following chemotherapy treatments. It focuses on understanding the potential benefits and outcomes of this approach.
- Who can participate: Adults over 18 with histologically confirmed pancreatic adenocarcinoma at the LAPC stage, who have received at least 4 months of induction chemotherapy and show stable disease or partial response, may participate if they are eligible for surgery as determined by a local medical team.
- Study details: Participants will undergo surgery after chemotherapy if feasible. The study will focus on evaluating survival and quality of life outcomes. A placebo will not be used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand